Provider QP31-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™ Read More
Provider QP25-20 Pharmacy Benefit Exclusion for Injectafer®, Feraheme®, Venofer®, INFeD®, Ferrlecit®, and generic Ferrlecit® Read More
Provider QP24-20 Pharmacy Benefit Update – Addition of Drugs to Existing Prior Authorization (PA) with Quantity Limit (QL) Programs Read More
